A critical appraisal of long acting injectable antipsychotics: Translating research to clinics

被引:15
作者
Sreeraj, Vanteemar S.
Shivakumar, Venkataram
Rao, Naren P.
Venkatasubramanian, Ganesan [1 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Neurobiol Res Ctr, Schizophrenia Clin, Dept Psychiat, Bangalore, Karnataka, India
关键词
Antipsychotics; Long-acting injections; Treatment resistance; Schizophrenia; Bipolar disorder; TREATMENT-RESISTANT SCHIZOPHRENIA; PALIPERIDONE PALMITATE; HALOPERIDOL DECANOATE; MAINTENANCE TREATMENT; DEPOT ANTIPSYCHOTICS; ORAL ANTIPSYCHOTICS; RELAPSE PREVENTION; BRAIN VOLUMES; RISPERIDONE; METAANALYSIS;
D O I
10.1016/j.ajp.2017.03.018
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Long acting injections (LAI) are an effective alternative mode of administration of antipsychotics, less commonly used in clinical practice. Gap in knowledge base is an important source of attitudinal bias. Current article is focused on reviewing the literature for the principles underlying the choice, initiation, maintenance, switch and termination of an LAI; historical, pharmacological and clinical factors implicating the rationale of using LAI against oral agents and older against newer LAIs. Evidences available in clinical and basic psychopharmacological researches are critically appraised, highlighting the lacunae in our understanding. It is endeavored to open the window for the studies to be carried forward in the future answering critical questions which could lay a stronger base for clinical utility of different LAIs. Thus, this article tries to acquaint clinicians with the translatable knowledge imparted from the research and riposte queries for the researchers to explore in relation to LAI. (C) 2017 Elsevier B.V.All rights reserved.
引用
收藏
页码:57 / 64
页数:8
相关论文
共 62 条
[1]  
Adams CE, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.cd000307, DOI 10.1002/14651858.CD000307]
[2]   Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching [J].
Agid, Ofer ;
Schulze, Laura ;
Arenovich, Tamara ;
Sajeev, Gautam ;
McDonald, Krysta ;
Foussias, George ;
Fervaha, Gagan ;
Remington, Gary .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (09) :1017-1022
[3]   How study designs influence comparative effectiveness outcomes: The case of oral versus long-acting injectable antipsychotic treatments for schizophrenia [J].
Alphs, Larry ;
Schooler, Nina ;
Lauriello, John .
SCHIZOPHRENIA RESEARCH, 2014, 156 (2-3) :228-232
[4]  
[Anonymous], 2015, MAUDSLEY PRESCRIBING
[5]  
ANTELMAN SM, 1981, BIOL PSYCHIAT, V16, P717
[6]   Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia [J].
Bartzokis, George ;
Lu, Po H. ;
Raven, Erika P. ;
Amar, Chetan P. ;
Detore, Nicole R. ;
Couvrette, Alexander J. ;
Mintz, Jim ;
Ventura, Joseph ;
Casaus, Laurie R. ;
Luo, John S. ;
Subotnik, Kenneth L. ;
Nuechterlein, Keith H. .
SCHIZOPHRENIA RESEARCH, 2012, 140 (1-3) :122-128
[7]   Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia A Randomized Clinical Trial [J].
Berwaerts, Joris ;
Liu, Yanning ;
Gopal, Srihari ;
Nuamah, Isaac ;
Xu, Haiyan ;
Savitz, Adam ;
Coppola, Danielle ;
Schotte, Alain ;
Remmerie, Bart ;
Maruta, Nataliya ;
Hough, David W. .
JAMA PSYCHIATRY, 2015, 72 (08) :830-839
[8]   Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs [J].
Bossie, Cynthia A. ;
Alphs, Larry D. ;
Correll, Christoph U. .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (05) :272-281
[9]   The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal [J].
Brissos, Sofia ;
Ruiz-Veguilla, Miguel ;
Taylor, David ;
Balanza-Martinez, Vicent .
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2014, 4 (05) :198-219
[10]   Antipsychotic treatment of schizophrenia: An update [J].
Bruijnzeel, Dawn ;
Suryadevara, Uma ;
Tandon, Rajiv .
ASIAN JOURNAL OF PSYCHIATRY, 2014, 11 :3-7